Thad Cochran bought WSHFX (WSHFX)
Thad Cochran (R-MS), a U.S. Senator, has disclosed 1 trade in WSHFX (WSHFX) since 2015, a single purchase, worth an estimated $175K in disclosed volume (the midpoint of the dollar ranges members report, not exact amounts).
The trade highlighted here is a purchase: Thad Cochran bought $100,001 - $250,000 of WSHFX (WSHFX) on December 16, 2015. Since that trade, WSHFX is up +4.16% against the S&P 500 up +317.34%, an outperformance of -313.17%.
Data updated
Thad Cochran's WSHFX trades vs the price
WSHFX is up +4.16% since Thad Cochran bought on December 16, 2015, versus +317.34% for the S&P 500.
Performance since this trade
All Thad Cochran WSHFX trades
Thad Cochran & WSHFX trading FAQ
Is it legal for Thad Cochran to trade WSHFX (WSHFX) stock?
Yes. Members of Congress are allowed to trade individual stocks, including WSHFX (WSHFX), but the STOCK Act of 2012 requires them to publicly disclose each transaction within 45 days. Quantellect tracks those disclosures; this page does not imply the trade was improper.
When did Thad Cochran buy WSHFX?
Thad Cochran disclosed a purchase of $100,001 - $250,000 of WSHFX (WSHFX) on December 16, 2015, according to public STOCK Act filings.
How has WSHFX performed since Thad Cochran's trade?
Since Thad Cochran bought WSHFX on December 16, 2015, the stock is up +4.16%, versus +317.34% for the S&P 500 over the same period, an outperformance of -313.17%.
How soon must members of Congress disclose a trade?
Under the STOCK Act, members of Congress must publicly report a covered transaction within 45 days of the trade. Filings can still be delayed, amended, or contain errors.
Where can I see all congressional WSHFX trades?
Quantellect tracks every disclosed congressional trade in WSHFX (WSHFX) on the WSHFX congressional trading page, which aggregates filings across all members of Congress.
Thad Cochran's WSHFX tradesAll congressional filings for WSHFXThad Cochran's full profile
Not investment advice. Congressional trading data is sourced from public STOCK Act disclosures, which are filed with a delay and may contain errors or be revised. Estimated prices and post-trade returns are derived algorithmically from public filings and end-of-day market data and describe historical activity, not a recommendation. Always do your own research and consult a licensed financial advisor before making investment decisions.